576
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Resveratrol improves follicular development of PCOS rats via regulating glycolysis pathway and targeting SIRT1

, , , , &
Pages 153-165 | Received 06 Apr 2022, Accepted 13 Sep 2022, Published online: 21 Oct 2022

References

  • Anastácio A, Rodriguez-Wallberg KA, Chardonnet S, Pionneau C, Fédérici C, Almeida Santos T, Poirot C. 2017. Protein profile of mouse ovarian follicles grown in vitro. Mol Hum Reprod. 23(12):827–841.
  • Banaszewska B, Wrotyńska-Barczyńska J, Spaczynski RZ, Pawelczyk L, Duleba AJ. 2016. Effects of resveratrol on polycystic ovary syndrome: A double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 101(11):4322–4328.
  • Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al. 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 444(7117):337–342.
  • Baur JA, Sinclair DA. 2006. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 5(6):493–506.
  • Boland NI, Humpherson PG, Leese HJ, Gosden RG. 1994. The effect of glucose metabolism on murine follicle development and steroidogenesis in vitro. Hum Reprod. 9(4):617–623.
  • Brenjian S, Moini A, Yamini N, Kashani L, Faridmojtahedi M, Bahramrezaie M, Khodarahmian M, Amidi F. 2020. Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers. Am J Reprod Immunol. 83(1):e13186.
  • Chang HC, Guarente L. 2014. SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab. 25(3):138–145.
  • Charalampakis V, Tahrani AA, Helmy A, Gupta JK, Singhal R. 2016. Polycystic ovary syndrome and endometrial hyperplasia: an overview of the role of bariatric surgery in female fertility. Eur J Obstet Gynecol Reprod Biol. 207:220–226.
  • Ding L, Gao F, Zhang M, Yan W, Tang R, Zhang C, Chen ZJ. 2016. Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome. Fertil Steril. 105(5):1330–1337.e1333.
  • Dubey P, Shi T, Coltharp M, Reddy S. 2022. Effects of resveratrol on metabolic, biochemical, and endocrine manifestations in polycystic ovary syndrome. Dietetics. 1(2):66–77.
  • Ergenoglu M, Yildirim N, Yildirim AG, Yeniel O, Erbas O, Yavasoglu A, Taskiran D, Karadadas N. 2015. Effects of resveratrol on ovarian morphology, plasma anti-mullerian hormone, IGF-1 levels, and oxidative stress parameters in a rat model of polycystic ovary syndrome. Reprod Sci. 22(8):942–947.
  • Escobar-Morreale HF. 2018. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 14(5):270–284.
  • Furat Rencber S, Kurnaz Ozbek S, Eraldemır C, Sezer Z, Kum T, Ceylan S, Guzel E. 2018. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study. J Ovarian Res. 11(1):55.
  • González-Fernández R, Martín-Ramírez R, Rotoli D, Hernández J, Naftolin F, Martín-Vasallo P, Palumbo A, Ávila J. 2019. Granulosa-lutein cell sirtuin gene expression profiles differ between normal donors and infertile women. IJMS. 21(1):295.
  • Han Y, Luo H, Wang H, Cai J, Zhang Y. 2017. SIRT1 induces resistance to apoptosis in human granulosa cells by activating the ERK pathway and inhibiting NF-κB signaling with anti-inflammatory functions. Apoptosis. 22(10):1260–1272.
  • Harris SE, Maruthini D, Tang T, Balen AH, Picton HM. 2010. Metabolism and karyotype analysis of oocytes from patients with polycystic ovary syndrome. Hum Reprod. 25(9):2305–2315.
  • Herrick JR, Lane M, Gardner DK, Behboodi E, Memili E, Blash S, Echelard Y, Krisher RL. 2006. Metabolism, protein content, and in vitro embryonic development of goat cumulus-oocyte complexes matured with physiological concentrations of glucose and L-lactate. Mol Reprod Dev. 73(2):256–266.
  • Kitada M, Ogura Y, Monno I, Koya D. 2019. Sirtuins and type 2 diabetes: role in inflammation, oxidative stress, and mitochondrial function. Front Endocrinol (Lausanne). 10:187.
  • Liang A, Huang L, Liu H, He W, Lei X, Li M, Li S, Liang H, Chen G, Tang J, et al. 2021. Resveratrol improves follicular development of PCOS rats by regulating the glycolytic pathway. Mol Nutr Food Res. 65(24):e2100457.
  • Liu Q, Xie YJ, Qu LH, Zhang MX, Mo ZC. 2019. Dyslipidemia involvement in the development of polycystic ovary syndrome. Taiwan J Obstet Gynecol. 58(4):447–453.
  • Lu C, Hutchens EG, Farhy LS, Bonner HG, Suratt PM, McCartney CR. 2018. Influence of sleep stage on LH pulse initiation in the normal late follicular phase and in polycystic ovary syndrome. Neuroendocrinology. 107(1):60–72.
  • Makanji Y, Tagler D, Pahnke J, Shea LD, Woodruff TK. 2014. Hypoxia-mediated carbohydrate metabolism and transport promote early-stage murine follicle growth and survival. Am J Physiol Endocrinol Metab. 306(8):E893–E903.
  • Mansour A, Samadi M, Sanginabadi M, Gerami H, Karimi S, Hosseini S, Shirzad N, Hekmatdoost A, Mahdavi-Gorabi A, Mohajeri-Tehrani MR, et al. 2021. Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS. Clin Nutr (Edinburgh, Scotland). 40(6):4106–4112.
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28(7):412–419.
  • Morgante G, Massaro MG, Di Sabatino A, Cappelli V, De Leo V. 2018. Therapeutic approach for metabolic disorders and infertility in women with PCOS. Gynecol Endocrinol. 34(1):4–9.
  • Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Tapanainen JS. 2000. Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome. Hum Reprod. 15(6):1266–1274.
  • Osuka S, Nakanishi N, Murase T, Nakamura T, Goto M, Iwase A, Kikkawa F. 2019. Animal models of polycystic ovary syndrome: a review of hormone-induced rodent models focused on hypothalamus-pituitary-ovary axis and neuropeptides. Reprod Med Biol. 18(2):151–160.
  • Pauli JR, Ropelle ER, Cintra DE, De Souza CT, da Silva AS, Moraes JC, Prada PO, de Almeida Leme JA, Luciano E, Velloso LA, et al. 2010. Acute exercise reverses aged-induced impairments in insulin signaling in rodent skeletal muscle. Mech Ageing Dev. 131(5):323–329.
  • Peng MF, Tian S, Song YG, Li CX, Miao MS, Ren Z, Li M. 2021. Effects of total flavonoids from Eucommia ulmoides Oliv. leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet. J Ethnopharmacol. 273:113947.
  • Peralta OA, Bucher D, Angulo C, Castro MA, Ratto MH, Concha I. 2016. Tissue localization of GM-CSF receptor in bovine ovarian follicles and its role on glucose uptake by mural granulosa cells. Anim Reprod Sci. 170:157–169.
  • Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, et al. 2012. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 15(5):675–690.
  • Tian B, Liu J. 2020. Resveratrol: a review of plant sources, synthesis, stability, modification and food application. J Sci Food Agric. 100(4):1392–1404.
  • Wang MX, Yin Q, Xu X. 2020. A rat model of polycystic ovary syndrome with insulin resistance induced by letrozole combined with high fat diet. Med Sci Monit. 26:e922136.
  • Wójcik M, Krawczyńska A, Antushevich H, Herman AP. 2018. Post-receptor inhibitors of the GHR-JAK2-STAT pathway in the growth hormone signal transduction. IJMS. 19(7):1843.
  • Yarmolinskaya M, Bulgakova O, Abashova E, Borodina V, Tral T. 2021. The effectiveness of resveratrol in treatment of PCOS on the basis of experimental model in rats. Gynecol Endocrinol. 37(sup1):54–57.
  • Yazir Y, Utkan T, Gacar N, Aricioglu F. 2015. Resveratrol exerts anti-inflammatory and neuroprotective effects to prevent memory deficits in rats exposed to chronic unpredictable mild stress. Physiol Behav. 138:297–304.
  • Zhang N, Zhuang L, Gai S, Shan Y, Wang S, Li F, Chen L, Zhao D, Liu X. 2021. Beneficial phytoestrogenic effects of resveratrol on polycystic ovary syndromein rat model. Gynecol Endocrinol. 37(4):337–341.
  • Zhang T, Du X, Zhao L, He M, Lin L, Guo C, Zhang X, Han J, Yan H, Huang K, et al. 2019. SIRT1 facilitates primordial follicle recruitment independent of deacetylase activity through directly modulating Akt1 and mTOR transcription. FASEB J. 33(12):14703–14716.
  • Zhang S, Tu H, Yao J, Le J, Jiang Z, Tang Q, Zhang R, Huo P, Lei X. 2020. Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway. Reprod Biol Endocrinol. 18(1):58.
  • Zhao S, Xu H, Cui Y, Wang W, Qin Y, You L, Chan WY, Sun Y, Chen ZJ. 2016. Metabolic actions of insulin in ovarian granulosa cells were unaffected by hyperandrogenism. Endocrine. 53(3):823–830.
  • Zheng Q, Li Y, Zhang D, Cui X, Dai K, Yang Y, Liu S, Tan J, Yan Q. 2017. ANP promotes proliferation and inhibits apoptosis of ovarian granulosa cells by NPRA/PGRMC1/EGFR complex and improves ovary functions of PCOS rats. Cell Death Dis. 8(10):e3145.
  • Zhu JL, Chen Z, Feng WJ, Long SL, Mo ZC. 2019. Sex hormone-binding globulin and polycystic ovary syndrome. Clin Chim Acta. 499:142–148.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.